Midnight is a proprietary sativa-dominant strain that has an approximately equal ratio of CBD to THC. Patients report that Midnight has a relaxing effect. Midnight may be ideal for new cannabis users who desire lower levels of THC, the psychoactive compound found in cannabis.
Midnight was licensed to Jay Pharma for pharmaceutical and over-the-counter use in cancer indications outside of Israel. Jay Pharma plans to use data collected from patients who are using, or have used, Midnight to guide future surveillance studies and/or clinical development efforts.